mrk

Inside Wall Street: Interest in Genomic Research Sector Heats Up Again

A secluded sector of biotechnology -- DNA sequencing and genetic analysis -- is hot once again on Wall Street. Leaders in the sector, like Ilumina, Life Technologies, and Human Genome Sciences, outscored most other biotechs last year.

Merck's Diarrhea Drug Could be First in 30 Years

A Merck-licensed drug to fight a bacteria blamed for increasing rates of deadly diarrhea in hospitals and nursing homes was found to cut repeat infections by 72%. The drug reduces the risk of re-infection by the bug and its more virulent new strain more than in patients taking only antibiotics.

American trio share Nobel prize for hot area in pharma research

Is a U.K. teen's death a setback for GSK's cervical cancer vaccine?

HIV vaccine: After 25 years of failure, an experimental drug offers hope

AstraZeneca sales-rep notes reveal troubling relationship with doctors

More questions about Merck's Gardasil published in 'JAMA'

Merck, Schering-Plough shareholders approve the merger

Ahead of the deal: Merck and Schering-Plough set to vote on merger Friday

Sanofi-Aventis buys Merck's stake in Merial for $4 billion

Conflicting economic data leads stocks slightly lower

Stocks climb slightly despite more earnings pessimism

Stocks dive as investors remember recession's not over

AstraZeneca, Merck to collaborate on early stage cancer drugs

Bad news on banks, Treasuries and GM sinks stocks